Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Completed

The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.

FDA Recall Z-1518-2022 · Posted None

Recall StatusCompleted
Product CodeMZP
Date Initiated2022-07-19
Product Quantity1

Reason for Recall

Incorrect optical calibration

Firm Action

The recalling firm issued a letter dated 7/19/2022 via Abbott representative delivery on 7/19/2022 confirming the issue the customer had with their instrument. The letter also said the impacted ADU4 module was taken out of service on 1/25/2022 and was then replaced with a new module on 3/22/2022. The letter discussed the potential impact and the necessary actions to take which included completing and returning the Customer Reply Form and reviewing this information with laboratory personnel and retain the communication for future reference.

Root Cause

Nonconforming Material/Component

Distribution Pattern

There was only foreign distribution to Italy.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑